| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_29fb007e9b6815b4b0ccb23b8f9e59d3 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12R- |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H-
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K-
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P21-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-19
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N-
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P- |
| filingDate |
1988-03-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4fe9c41e0ff7a9201c66d863bb1a14e9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c62776b8838f92ca12274d2a82328b73
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_93271711c20569ccc37dd44fea9d7707
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b8e7b6a30acd9374d464dabca819ad41
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_132c2986c14218cc958bc811cdabdde2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fd95d508ce0d465d54b31fd366a0ce92
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a2d56b22c2bcccaedc66ada3b6f912b2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ff539e2f2940076fd6c267cf8c7f7066
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c3434ba3e4055e6c99fd981eac343b22 |
| publicationDate |
1993-03-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
HU-207342-B |
| titleOfInvention |
Process for producing human or mouceleukemie inhibitor factor /lif/ and pharmaceutical compositions of lif activity and process for purifying lif after or without glycozilation |
| abstract |
The present invention relates to a method for purifying glycosylated or non-glycosylated LIF using chromatographic methods. It is a further object of the present invention to provide LIF in substantially pure, recombinant DNA technology in a prokaryotic, yeast or mammalian host cell. The invention also encompasses the preparation of pharmaceutical compositions having LIF function. EN 207 342 B Scope of the description: 58 pages (including 35 sheets) |
| priorityDate |
1987-04-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |